Additional functionally relevant Rac1 mutations include Ala159 (predominantly in head and neck cancers), Asn92, (melanoma, myeloma and sarcoma), Cys157 and the canonical Gly12 (mainly prostate cancer) and Gly61 (testicular germ cell cancer). This evidence concerns the gene RAC1 and melanoma.